Filtered By:
Procedure: Hemodiafiltration
Therapy: Dialysis
This page shows you your search results in order of date.
Order by Relevance | Date
Total 362 results found since Jan 2013.
Endocrine disruptors in dialysis therapies: A literature review
Environ Int. 2023 Jul 17;178:108100. doi: 10.1016/j.envint.2023.108100. Online ahead of print.ABSTRACTEndocrine disrupting chemicals (EDCs) were defined as "an exogenous substance or mixture that alters function(s) of the endocrine system and consequently causes adverse health effects". These compounds are mainly eliminated by the renal route. However, patients with end-stage kidney disease treated by dialysis (ESKDD) can no longer eliminate these EDCs efficiently. Furthermore, EDCs exposure could occur via leaching from medical devices used in dialysis therapy. As a result, ESKDD patients are overexposed to EDCs. The aims...
Source: Environment International - July 23, 2023 Category: Environmental Health Authors: Guillaume Cambien Antoine Dupuis J érémy Guihenneuc Marc Bauwens Mohamed Belmouaz Sarah Ayraud-Thevenot Source Type: research
Effects of high-flux hemodialysis and hemodiafiltration on the mortality of patients with end-stage kidney disease: a meta-analysis
CONCLUSIONS: Compared with HDF, HFHD has no obvious benefits for all-cause mortality or cardiovascular mortality in patients with ESKD, but reduced risk of infection-related death.PMID:37427760 | PMC:PMC10334859 | DOI:10.1080/0886022X.2022.2147436
Source: Renal Failure - July 10, 2023 Category: Urology & Nephrology Authors: Sihui Ma Nan Pu Juan Ma Source Type: research
Minimized Hemodiafiltration for Extracorporeal Membrane Oxygenation in Infants
CONCLUSION: There were no complications with the minimized HDF system in all 15 applications. It allows safe patient volume management when treating infants with ECMO, with effective elimination of urinary substances.PMID:37037222 | DOI:10.1055/s-0043-1766107
Source: The Thoracic and Cardiovascular Surgeon - April 10, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Nicola Kwapil Andreas Teske Sven Dittrich Robert Blumauer Michela Cuomo Ariawan Purbojo Frank M ünch Source Type: research
Renal replacement therapy removes a large number of nitric oxide donors responsible for the nitrate-nitrite-nitric oxide pathway
CONCLUSION: The high nitric oxide clearance may have partly contributed to the high cardiovascular and coronavirus-2 mortality risk in patients on dialysis.PMID:36825795 | DOI:10.1177/03913988231157427
Source: The International Journal of Artificial Organs - February 24, 2023 Category: Transplant Surgery Authors: Yoshihiro Tange Reo Sunakawa Shigenori Yoshitake Source Type: research
